TCT 114: Impact of New Pacemaker Implantation After TAVR in Low/Intermediate-Risk Patients: A Propensity-Matched Analysis from a United States Registry

<p>Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: </p><ul><li>TAVR proctorship - Boston Scientific Corporation; Medtronic; Merit Medical Systems</li></ul>